Medpace Holdings, Inc. (MEDP) compared with its closest peers (CRL, INCY, IQV, ULS, NTNX): P/E 35.6 vs industry 30.0. Peer set by Business Services; 10 comparable business services companies. First-party data.
Charles River Laboratories International, Incyte and IQVIA share Medpace's sub-industry, commercial research labs; UL Solutions shares Medpace's business model, clinical labs / cro services.
| Company | Market Cap | P/E |
|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | $14.20B | -70.0 |
| Incyte Corporation (INCY) | $25.92B | 20.1 |
| IQVIA Holdings Inc. (IQV) | $43.31B | 38.7 |
| UL Solutions Inc. (ULS) | $14.88B | 29.5 |
| Nutanix, Inc. (NTNX) | $17.96B | 59.8 |
| Dropbox, Inc. (DBX) | $7.88B | 17.8 |
| RingCentral, Inc. (RNG) | $5.69B | 48.2 |
| FTAI Aviation Ltd. (FTAI) | $20.60B | 39.7 |
| Zillow Group, Inc. Class C (Z) | $8.65B | 141.8 |
| Zillow Group, Inc. Class A (ZG) | $8.46B | 153.8 |
| Stock P/E | 35.6 |
| Sector P/E (Technology) | 34.1 |
| Industry P/E (Business Services) | 30.0 |
| vs Sector | 4.4% |
| vs Industry | 19.0% |
MEDP overview · MEDP earnings · MEDP financials · MEDP KPIs · MEDP documents · MEDP ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.